Genetic interactions between activin type IIB receptor and Smad2 genes in asymmetrical patterning of the thoracic organs and the development of pancreas islets

被引:25
作者
Goto, Yutaka
Nomura, Masatoshi
Tanaka, Kimitaka
Kondo, Akiyo
Morinaga, Hidetaka
Okabe, Taijirou
Yanase, Toshihiko
Nawata, Hajime
Takayanagi, Ryoichi
Li, En
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Higashi Ku, Fukuoka 812, Japan
[2] Novartis Inst Biomed Res, Cambridge, MA 02139 USA
[3] Massachusetts Gen Hosp E, Cardiovasc Res Ctr, Harvard Med Sch, Dept Med, Charlestown, MA USA
关键词
activin receptor type IIB; Smad2; pancreas islet; left-right asymmetry; diabetes;
D O I
10.1002/dvdy.21303
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 [人体解剖与组织胚胎学];
摘要
Signaling through activin type IIB receptor (ActRIIB) has been shown to regulate the axial formation and the development of foregut-derived organs such as the pancreas in mice. Here, we provide genetic evidence that ActRIIB and Smad2 genes cooperatively regulated asymmetrical patterning of the thoracic organs and pancreas development in. mice. The loss of one allele of Smad2 on ActRIIB(-/-) background resulted in the increased severity of ActRIIB(-/-) phenotypes, including right pulmonary isomerism and complex cardiac malformations, and resulted in 100% frequency of death soon after birth. Of interest, 14% of compound heterozygous ActRIIB(+/-)Smad2(+/-) mice exhibited the ActRIIB(-/-) phenotypes and died soon after birth. In the pancreas, hypoplastic islets were found not only in ActRIIB(-/-) but also in Smad2(+/-) mice. A more severe phenotype was also found in ActRIIB(+/-)Smad2(+/-) mice. As well, these mutant mice exhibited impaired glucose tolerance in a gene dosage-sensitive manner. This genetic evidence strongly suggested that ActRIIB and Smad2 function in the same signaling pathway to regulate axial patterning and pancreas islet formation by means of a threshold mechanism.
引用
收藏
页码:2865 / 2874
页数:10
相关论文
共 31 条
[1]
NOVEL ACTIVIN RECEPTORS - DISTINCT GENES AND ALTERNATIVE MESSENGER-RNA SPLICING GENERATE A REPERTOIRE OF SERINE THREONINE KINASE RECEPTORS [J].
ATTISANO, L ;
WRANA, JL ;
CHEIFETZ, S ;
MASSAGUE, J .
CELL, 1992, 68 (01) :97-108
[2]
Transforming growth factor-β1 in the developing mouse pancreas:: a potential regulator of exocrine differentiation [J].
Crisera, CA ;
Maldonado, TS ;
Kadison, AS ;
Li, M ;
Alkasab, SL ;
Longaker, MT ;
Gittes, GK .
DIFFERENTIATION, 2000, 65 (05) :255-259
[3]
DERYNCK R, 1997, BIOCHIM BIOPHYS ACTA, V1333, P105
[4]
No evidence for linkage or for diabetes-associated mutations in the activin type 2B receptor gene (ACVR2B) in French patients with mature-onset diabetes of the young or type 2 diabetes [J].
Dupont, S ;
Hani, EH ;
Cras-Méneur, C ;
De Matos, F ;
Lobbens, S ;
Lecoeur, C ;
Vaxillaire, M ;
Scharfmann, R ;
Froguel, P .
DIABETES, 2001, 50 (05) :1219-1221
[5]
FEIJEN A, 1994, DEVELOPMENT, V120, P3621
[6]
EXPRESSION OF IMMUNOREACTIVE ACTIVIN-A IN FETAL-RAT PANCREAS [J].
FURUKAWA, M ;
ETO, Y ;
KOJIMA, I .
ENDOCRINE JOURNAL, 1995, 42 (01) :63-68
[7]
GDF11 modulates NGN3+ islet progenitor cell number and promotes β-cell differentiation in pancreas development [J].
Harmon, EB ;
Apelqvist, AA ;
Smart, NG ;
Gu, XY ;
Osborne, DH ;
Kim, SK .
DEVELOPMENT, 2004, 131 (24) :6163-6174
[8]
PKCλ regulates glucose-induced insulin secretion through modulation of gene expression in pancreatic β cells [J].
Hashimoto, N ;
Kido, Y ;
Uchida, T ;
Matsuda, T ;
Suzuki, K ;
Inoue, H ;
Matsumoto, M ;
Ogawa, W ;
Maeda, S ;
Fujihara, H ;
Ueta, Y ;
Uchiyama, Y ;
Akimoto, K ;
Ohno, S ;
Noda, T ;
Kasuga, M .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (01) :138-145
[9]
TGF-beta signalling from cell membrane to nucleus through SMAD proteins [J].
Heldin, CH ;
Miyazono, K ;
tenDijke, P .
NATURE, 1997, 390 (6659) :465-471
[10]
Kim SK, 2000, GENE DEV, V14, P1866